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Abstract— The relationship between changes in gene expression and physical characteristics associated with Down syndrome
is not well understood. Chromosome 21 genes interact with nonchromosome 21 genes to produce Down syndrome characteristics.
This indirect influence, however, is difficult to empirically define
due to the number, size, and complexity of the involved gene
regulatory networks. This work links chromosome 21 genes to
non-chromosome 21 genes known to interact in a Down syndrome
phenotype through a reachability analysis of labeled transition graphs extracted from published gene regulatory network
databases. The analysis provides new relations in a recently
discovered link between a specific gene and Down syndrome
phenotype. This type of formal analysis helps scientists direct
empirical studies to unravel chromosome 21 gene interactions
with the hope for therapeutic intervention.

I. I NTRODUCTION
Researchers currently hypothesize that cancers and other
physical ailments are caused by duplication of genes on
chromosomes [1]. Chromosomes are made up of genes that encode information about physical characteristics or phenotypes.
Through empirical analysis, systems biologists determine how
genes are linked to certain phenotypes. Knowing how genes
interact to express specific phenotypes is a critical step for
therapeutic intervention in many diseases. The large number of
genes found in an individual and the possible gene interactions
make it difficult to manually discern how gene regulatory
networks influence phenotypic characteristics.
Patients with Down syndrome (DS) have an extra copy of
chromosome 21 (chr. 21) and have phenotypes like abnormal brain and facial features as well as mental retardation.
DS results from three copies of approximately 350 chr. 21
genes and has many well defined phenotypes that make it
an excellent model to understand gene regulatory networks.
By understanding changes that occur in this model, gene
regulatory networks in other diseases that are not as welldefined genetically or phenotypically can be better understood.
Phenotypes are generated by interactions between genes
that are described by gene regulatory networks. Each gene
regulatory network is a complex feedback circuit that is constructed through large, costly, and time consuming empirical
studies. The regulatory networks once understood, however,
provide a wealth of information. For example, pharmaceutical
researchers use gene regulatory network diagrams to design

compounds that inhibit the expression of certain genes. In
other words, pharmaceutical researchers are designing drugs
to target genes involved in specific medical conditions; the
drugs essentially manipulate the gene regulatory networks to
produce a desired outcome.
DS researchers and systems biologists believe that changes
in expression levels of one or more genes on the extra copy
of chr. 21 lead to specific DS phenotypes. Even though DS
researchers and bioinformaticians have documented elevated
expression levels of chr. 21 genes in DS, they have been
unable, for the most part, to directly link a specific chr. 21
gene to a particular phenotype.
Research in human and mouse models shows that there are
modifier genes, not found on chr. 21, that contribute to DS
phenotypes [2], [3]. For example, the Sonic hedgehog gene
(SHH) in the Hedgehog signaling pathway has been directly
linked to a DS brain phenotype [2]. It is, however, unknown
how the SHH gene is linked to chr. 21 genes. The work in this
paper helps researchers focus on specific modifier and chr. 21
genes for empirical studies.
Researchers often relate chr. 21 genes to modifier genes
by manually examining published gene regulatory network
databases. These databases, [4]–[6], are exceptionally complex and regularly evolve as new data is discovered through
empirical studies. Manual extraction of indirect connections
between chr. 21 and modifier genes is not feasible in such a
large, concurrent, and connected system. An automated formal
analysis is required to assist researchers in understanding gene
regulatory networks important in DS.
We use a formal approach to analyze gene regulatory
networks that are mined from different biological databases.
We build a single labeled transition graph from these databases
by defining a way of connecting the gene regulatory networks.
We perform an exhaustive reachability analysis on the graph
using a randomized breadth-first search (BFS). Randomized
BFS gives a sample of shortest path connections between
modifier genes and chr. 21 genes. The random paths are
tabulated and graphed to show researchers the names and
frequencies of genes found in these paths. We hypothesize that
genes frequently found in paths connecting modifier and chr.
21 genes are more likely to be involved in a specific phenotype.
Our results demonstrate a possible relationship between a non-

chr. 21 modifier gene and chr. 21 genes. These relationships
help DS researchers to direct resources for future empirical
studies.
The principle contributions of this work are: (1) a biologically feasible technique connecting different gene regulatory
networks into a single labeled transition graph suitable for
formal analysis; (2) a reachability analysis using randomized
BFS to generate different traces between chr. 21 genes and
modifier genes; and (3) tabulated results showing potential
interactions between specific chr. 21 genes and the SHH
modifier gene.
II. R ELATED W ORK
Several databases store pictorial representations of empirically curated gene regulatory networks [4]–[6]. Among all the
databases, KEGG [4], currently has the largest amount of data
in the most comprehensible and accessible format. It provides
175 pathways with over 12,000 genes from the human genome.
Many of its pathways include both a pictorial and XML
representation; although, the XML descriptors often have
fewer defined interactions than those defined in the pictorial
descriptors. Another source of gene interactions is found in a
PubMed abstracts database [7]. PubMed is a premier journal
index for published bio-medical articles. Existing research,
[7], extracts gene relationships from PubMed using natural
language processing algorithms. The work in this paper uses
the KEGG database and the PubMed extraction to build the
labeled transition graph of the gene regulatory networks.
State of the art pathway analyses tools such as
Cytoscape [8], Reactome [9], and Bind [10] visualize
gene regulatory networks. They provide some basic query
mechanisms to probe structure in the regulatory networks. The
queries, however, are simple and do not provide an ability
to derive indirect relationships between modifier and chr. 21
genes in a fully automated manner.
Other formal verification approaches that analyze regulatory
networks consider only a single network or pathway [11]–[14].
A single network is modeled in isolation to predict pathway
behavior based on the gene interaction rates. The work in
this paper abstracts many details of individual regulatory
networks to consider the interactions of the complete system
of regulatory networks. Where existing research, [11]–[14],
tries to understand intra-network interactions, we extend the
analysis to inter-network interactions in expressing a specific
phenotype.
III. G RAPH C ONSTRUCTION
We build a labeled transition graph from the KEGG and
PubMed databases. The process follows three steps: first,
we abstract the reactions and compounds in gene regulatory
networks in the KEGG database to create intra-pathway gene
interactions; second, we use gene interactions to create interpathway connections; and third, we add PubMed interactions
to the inter-pathway and intra-pathway connections. Adding
the gene-to-gene connections between individual pathways
essentially flattens the KEGG database in step two. The final

labeled transition graph is an over approximation of the actual
biological system. The process is illustrated in more detail
with a simple example.
Fig. 1(a) shows parts of gene regulatory networks and
metabolic pathways: the Hedgehog signaling pathway (HSP),
Basal cell carcinoma (BCC), and Alzheimer’s disease (AD)
regulatory networks. The rectangle boxes in each pathway
represent the genes in the regulatory networks. For example,
the Hedgehog signaling pathway shown in Fig. 1(a) contains
the genes SHH, PTCH, GLI and WNT1. An edge between
any two genes is a direct or indirect interaction between the
genes. We maintain scalability by abstracting away most of
the details in the actual biological system to focus purely
on gene interactions—direct and indirect. Results suggest that
the abstraction retains enough information to be meaningful.
Fig. 1(b) is the final labeled transition graph for the pathways
and PubMed relations shown in Fig. 1(a).
The abstract pathways form a set of intra-network gene
interactions. Each graph is a separate abstracted regulatory
network. For example, the abstract graph of the Hedgehog
signaling pathway contributes s0 , s1 , s4 , and s5 nodes to the
transition graph in Fig. 1(b). The intra-network connections
between the genes in the Hedgehog signaling pathway are
maintained in the transformation. The next step connects the
abstract networks to form an inter-network graph. The separate
abstract networks are connected by creating a set of nodes
labeled by both the gene and the network owning the gene.
Each node contains the gene label and the owning pathway
label. Once the set of nodes is known, then edges are created
between nodes that contain common gene labels. For example,
Fig. 1(a) shows that both HSP and BCC contain the PTCH
gene. As such, Fig. 1(b) connects state s1 to state s2 showing
a relation between the HSP and BCC pathways through the
common PTCH gene. The two different nodes labeled with
PTCH gene for the HSP and BCC networks enable us to
easily detect that PTCH is the gene which connects the HSP
and BCC networks. Connecting regulatory networks in this
way essentially flattens the KEGG database through gene
interactions.
The final step in building the inter-network graph augments
the XML data in the KEGG database with known interactions
published in the PubMed database using the work in [7]. In
essence, any gene pair related in PubMed is also related in the
inter-network graph. For example, the bottom right member of
Fig. 1(a) shows a relation defined in the PubMed database; it
connects the gene A2M to WNTI. The relation is expressed
in Fig. 1(b) by the edge between states s5 and s6 .
IV. A NALYSIS
DS researchers are interested in finding the gene interactions
between modifier genes (e.g., SHH gene) and chr. 21 genes.
We define a randomized BFS to find shortest path traces
between modifier genes and chr. 21 genes.
A regular BFS enumerates all nodes reachable in one-step
from the initial node before enumerating nodes reachable
in two-steps. This feature guarantees that the BFS finds the
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procedure Random BFS(s0 )
1: Visited := {s0 }
2: Queue.enqueue(s0 )
3: while (Queue) "= ∅ do
4:
s := Queue.dequeue
5:
if is chr 21 gene(s) then
6:
print “Report Path”
7:
Xsucc := get successors(s)
8:
s := randomize elements(Xsucc )
9:
for each s! ∈ Xsucc do
10:
if s! "∈ V isited then
11:
V isited := V isited ∪ {s! }
12:
Queue.enqueue(s! )

APP

Fig. 2.

Pseudo-code for randomized breadth-first search.
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Fig. 1. Converting a set of gene regulatory pathways into a labeled transition
graph. (a) KEGG pathways and PubMed Relations. (b) The corresponding
labeled transition graph.

shortest distance between the start node and another node of
interest. The search, however, deterministically generates the
same shortest trace between the two nodes in every single trial.
For example, the shortest distance between nodes s6 and s9 is
two steps in Fig. 1(b). The successors of node s6 are sorted
in some default order. If the successors are lexicographically
sorted where node s7 is inserted in the queue before s8 , the
BFS generates the trace s6 → s7 → s9 and does not generate
the trace s6 → s8 → s9 .
The labeled transition graph derived from the gene regulatory networks database is a highly connected graph. It has
approximately 12,000 nodes and one million edges. About
90% of the connections are a result of the abstraction applied
to the pathways while creating the inter-network connections.
The high degree of connectivity creates a large number of
unique shortest paths between two nodes in the graph. There
are different algorithms to find the k shortest paths between
two nodes in a graph such as the one presented by Eppstein
in [15]; however, to randomly sample different shortest traces
we use a randomized BFS for its algorithmic simplicity and
low complexity. Generating s6 → s7 → s9 is equally likely
as generating s6 → s8 → s9 in any trial of randomized BFS.
A randomized BFS generates a subset of the shortest paths
between modifier and chr. 21 genes. The pseudo-code for a

randomized BFS, [16], is presented in Fig. 2. The algorithm
is a variant of the regular BFS that randomizes the order of
successors before inserting them into a queue. Randomized
BFS generates shortest traces of all the gene interactions
from the initial state to nodes that represent chr. 21 genes
(is chr 21 gene). During the search, when we encounter a
node, s, labeled with a chr. 21 gene (line 5) we report the path
from the initial state to the node, s (line 6). We then continue
searching for paths connecting the initial state to nodes labeled
with other chr. 21 genes. Note that we maintain a set of visited
nodes and never visit the same node twice (lines 10 − 12). If
there is more than one shortest path from the initial state to a
node with a particular chr. 21 gene, each trial of randomized
BFS generates a subset of those traces.
V. R ESULTS
The analysis in this paper is designed to answer the following research questions: (a) How many chr. 21 genes are
connected to a modifier gene? (b) What is the length of the
shortest path between a chr. 21 gene and the modifier gene?
and (c) What are the gene interactions between a chr. 21
gene and the modifier gene? We summarize the analysis for
the SHH modifier gene and chr. 21 genes in the following
paragraphs.
To answer the research questions (a) and (b), we run a
single trial of randomized BFS starting from the SHH modifier
gene in the Hedgehog signaling pathway. During the search,
whenever we encounter a chr. 21 gene, we mark the chr. 21
gene as reachable from the SHH modifier gene and note the
length of the trace. Recall that a randomized BFS returns the
length of the shortest trace from the SHH gene to the particular
chr. 21 gene.
Randomized BFS finds 38 chr. 21 genes that are between 3
to 7 steps away from the SHH gene in the labeled transition
graph. Among the reachable chr. 21 genes, there are genes
that play a significant role in Alzheimer’s disease and other
cancers. This result is especially interesting to researchers
because virtually all individuals with DS have indicators of
Alzheimer’s disease by 40 years of age.
We run several trials of randomized BFS to answer research
question (c). The trials result in a large number of traces

VII. C ONCLUSION AND F UTURE W ORK

Fig. 3.
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This work defines a technique to build a labeled transition
graph from different biological databases. On this graph we
perform a reachability analysis using randomized BFS to
find gene interactions between modifier genes and chr. 21
genes. The analysis for the SHH modifier gene and chr. 21
genes gives an interesting set of genes for designing empirical studies. The same analysis can be used for determining
gene interactions in various modifier genes for DS and other
ailments. The representation of the different gene regulatory
pathways as single labeled transition graphs lends itself to a
more refined analysis. As future work, biologically interesting
questions can be posed in temporal logic to find traces that
satisfy the property.
R EFERENCES
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